There is evidence that elevated serum androgen levels are linked to higher breast cancer risk in post-menopausal women, and it is known that androgen receptor (AR) blockade may help treat some AR-positive breast cancers by inhibiting tumor growth, though this observed behavior varies with breast cancer subtype (50–52). The gene discussed is AR; the disease is breast carcinoma.